Janet Leeds from Portola Pharmaceuticals will present "PK-PD Modeling Used to Determine the Dosing Regimen of Andexanet Alfa for Reversal of Anticoagulation Due to Direct FXa Inhibitors in Patients with Acute Major Bleeding"